Agilent Technologies Acquires Manufacturer of Synthetic Nucleic Acids for Pharmaceutical and Biotech

Agilent Technologies Inc. (NYSE: A) today announced that it has acquired privately held SynPro Corp.. Financial details were not disclosed.

Source: Agilent Technologies